Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1187 of 5804
-
Shocking stroke recovery: nerve zaps + robots show promise
Symptom relief Recruiting nowStroke is one of the leading causes of death and permanent disability worldwide. Loss of upper extremity (UE) function after stroke significantly reduces independence and quality of life. Moreover, weakness in the respiratory muscles negatively affects trunk control and respirato…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New drug aims to ease symptoms of stiff heart muscle
Symptom relief Recruiting nowFORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxstat compared to placebo on top of Standard of Care in patients with symptomatic nHCM
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
AI could help family doctors catch hidden heart disease
Diagnosis Not yet recruitingThe DAISEA-ECG project aims to improve the diagnosis of heart diseases in primary care through the DeepECG platform, which combines ECG-AI and ECHONeXT algorithms. This study uses a stepped wedge design, where each Family Medicine Group acts as its own control. The FMGs will grad…
Phase: NA • Sponsor: Montreal Heart Institute • Aim: Diagnosis
Last updated Jun 26, 2026 19:10 UTC
-
Radioactive bullet targets Hard-to-Treat breast cancer
Disease control Recruiting nowThis is a FiH phase 1, open-label, two-stage, randomized trial to assess the safety, tolerability, and biodistribution of \[177Lu\]Lu-ABY-271 in subjects with HER2 positive metastatic breast cancer.
Phase: PHASE1 • Sponsor: Affibody • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug combo could simplify breast cancer treatment for younger women
Disease control Recruiting nowA prospective randomized trial designed to evaluate the mean decrease in Ki67 after 4 weeks of elacestrant monotherapy and in combination with leuprorelin in patients with early-stage HR+ BC. This preoperative study will enroll consecutive patients with early stage HR+ BC who are…
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Virtual reality takes on smoking: could VR training help students kick the habit?
Disease control CompletedThis study aims to evaluate the effect of Transtheoretical Model-based virtual reality-supported smoking cessation training on self-efficacy, competence levels, and smoking cessation behavior in smoking students. Although the use of virtual reality environments in addiction resea…
Phase: NA • Sponsor: ZELAL KAYA KOŞAR • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Less fluid may be better for sickle cell pain emergencies
Symptom relief Recruiting nowSickle cell disease (SCD) is a prevalent inherited blood disorder characterized by vaso-occlusive crises (VOCs), which lead to severe pain and complications. Despite hydration being a cornerstone of VOC management, the optimal fluid strategy remains uncertain. This study evaluate…
Phase: NA • Sponsor: Imam Abdulrahman Bin Faisal University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Could acupuncture plus brain zaps boost memory after stroke? new trial launches
Symptom relief Recruiting nowStroke is a global public health issue, and it has become a leading cause of death and disability in China. With the rapid aging of the Chinese population, its incidence rate is continuously rising. According to the "China Stroke Prevention and Treatment Report (2023)", on averag…
Phase: NA • Sponsor: Ruijie Ma • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Could cannabis oil calm autism behaviors? new study seeks answers
Symptom relief Recruiting nowThe goal of this clinical trial is to determine whether cannabidiol (CBD, 28%) combined with terpenes and a small amount of THC (1%) can help reduce symptoms of autism, and to evaluate the safety of this treatment. The main questions are: 1. Does this treatment improve behavior…
Phase: PHASE2 • Sponsor: Bazelet Nehushtan LtD. • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New TAVI technique aims to stop silent valve clots
Disease control Recruiting nowOptimized Expansion of the implanted transcatheter aortic valve to reduce hypoattenuating leaflet thickening in non-atrial fibrillation patients undergoing transcatheter aortic valve implantation (TAVI): an international, multicentre, randomized controlled trial. The objective i…
Phase: NA • Sponsor: Ole De Backer • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Shockwave before heart valve procedure may prevent bleeding in hardened arteries
Symptom relief Recruiting nowThe primary purpose of this study is to observe reduced access site complications in patients with heavily calcified common femoral arteries requiring Transcatheter Aortic Valve Replacement (TAVR)
Phase: NA • Sponsor: University of Tennessee Graduate School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Vaping prevention program put to the test in ontario high schools
Prevention OngoingVapes (also called e-cigarettes) have increased in popularity among youth in Canada and the United States. Youth who try vaping are at risk of becoming addicted and continuing to vape. To help combat the rise in vaping, there is an urgent need to identify effective ways to preven…
Phase: NA • Sponsor: University of Ontario Institute of Technology • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Heart shield after pregnancy: statin trial targets lasting damage
Disease control Recruiting nowThe objective is to conduct a double-blinded randomized controlled trial of atorvastatin vs. placebo among postpartum individuals with hypertensive disorders of pregnancy, to improve cardiovascular risk score postpartum. For this, 76 individuals with hypertensive disorders of pre…
Phase: PHASE4 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New scan could match breast cancer patients to best therapy
Diagnosis Recruiting nowThis is a prospective, multi-center, open-label, exploratory diagnostic phase II imaging trial for patients with metastatic breast cancer with at least one line of systemic therapy. The overarching aim of the HER2-Ex PET trial is to study the role of precision imaging utilizing …
Sponsor: Renske Altena • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
Can cannabis calm chemo nerve pain? new study seeks answers
Symptom relief Recruiting nowThis phase II trials evaluates how well different types of phytocannabinoids (cannabidiol \[CBD\] versus tetrahydrocannabinol \[THC\] and CBD formulation \[THC:CBD\]) work to reduce chronic chemotherapy-induced peripheral neuropathy among breast and colon cancer survivors. Chemot…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
New hope for tough lymphomas? daily pill trial launches
Disease control OngoingThe purpose of this clinical trial is to learn if the study drug pemigatinib is effective in treating patients with relapsed or refractory B-cell non-Hodgkin lymphomas.
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Waiting to clamp the cord: could 30 seconds save preterm babies?
Disease control Recruiting nowThe goal of this study is to evaluate whether delayed cord clamping improves early neonatal outcomes compared with immediate clamping in preterm birth. Preterm infants are at higher risk of neonatal complications, and the timing of cord clamping may influence placental transfusi…
Phase: NA • Sponsor: Faculty of Medicine of Tunis • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a tailored infusion schedule prevent fractures after stopping denosumab?
Disease control Recruiting nowDenosumab (Dmab) is a treatment for postmenopausal osteoporosis. However, its withdrawal is associated with a rebound phenomenon associated with an unexpected increased risk of vertebral fractures. Defining the optimal strategy for Dmab withdrawal is critically needed. Investigat…
Phase: PHASE4 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope for rare bleeding disorder: experimental drug aims to stop bleeding episodes
Disease control Recruiting nowThis study is evaluating an investigational drug, eptacog beta (EB), for the treatment and prevention of acute bleeding episodes in people with Glanzmann Thrombasthenia, a rare inherited bleeding disorder. Eptacog beta (EB) is not currently approved by the U.S. Food and Drug Admi…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New feeding strategy may stop leaky lymph fluid after esophageal surgery
Prevention Recruiting nowChyle leak (chylothorax) is a recognised complication following minimally invasive oesophagectomy for oesophageal cancer and may result in prolonged hospital stay, nutritional compromise, and need for additional interventions. Medium-chain triglyceride (MCT) feeds reduce lymphat…
Phase: NA • Sponsor: Royal College of Surgeons, Ireland • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC